Mesotten D - Search Results

1

Worldwide Survey of Nutritional Practices in PICUs.

Kerklaan D, Fivez T, Mehta NM, Mesotten D, van Rosmalen J, Hulst JM, Van den Berghe G, Joosten KF, Verbruggen SC. Kerklaan D, et al. Among authors: mesotten d. Pediatr Crit Care Med. 2016 Jan;17(1):10-8. doi: 10.1097/PCC.0000000000000542. Pediatr Crit Care Med. 2016. PMID: 26509815

2

Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort.

Meijs DAM, van Kuijk SMJ, Wynants L, Stessel B, Mehagnoul-Schipper J, Hana A, Scheeren CIE, Bergmans DCJJ, Bickenbach J, Vander Laenen M, Smits LJM, van der Horst ICC, Marx G, Mesotten D, van Bussel BCT; CoDaP Investigators. Meijs DAM, et al. Among authors: mesotten d. J Clin Epidemiol. 2022 Dec;152:257-268. doi: 10.1016/j.jclinepi.2022.10.015. Epub 2022 Oct 27. J Clin Epidemiol. 2022. PMID: 36309146 Free PMC article.

3

Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.

Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van Den Berghe G. Mesotten D, et al. J Clin Endocrinol Metab. 2002 Dec;87(12):5516-23. doi: 10.1210/jc.2002-020664. J Clin Endocrinol Metab. 2002. PMID: 12466347 Clinical Trial.

4

Clinical potential of insulin therapy in critically ill patients.

Mesotten D, Van den Berghe G. Mesotten D, et al. Drugs. 2003;63(7):625-36. doi: 10.2165/00003495-200363070-00001. Drugs. 2003. PMID: 12656643 Review.

5

Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy.

Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Mesotten D, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):219-26. doi: 10.1210/jc.2003-030760. J Clin Endocrinol Metab. 2004. PMID: 14715853 Clinical Trial.

6

Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness.

Mesotten D, Wouters PJ, Peeters RP, Hardman KV, Holly JM, Baxter RC, Van den Berghe G. Mesotten D, et al. J Clin Endocrinol Metab. 2004 Jul;89(7):3105-13. doi: 10.1210/jc.2003-032102. J Clin Endocrinol Metab. 2004. PMID: 15240578 Clinical Trial.

7

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.

Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Vanhorebeek I, et al. Among authors: mesotten d. Lancet. 2005 Jan 1-7;365(9453):53-9. doi: 10.1016/S0140-6736(04)17665-4. Lancet. 2005. PMID: 15639679

8

Changes within the GH/IGF-I/IGFBP axis in critical illness.

Mesotten D, Van den Berghe G. Mesotten D, et al. Crit Care Clin. 2006 Jan;22(1):17-28, v. doi: 10.1016/j.ccc.2005.09.002. Crit Care Clin. 2006. PMID: 16399017 Review.

9

Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness.

Mesotten D, Van den Berghe G. Mesotten D, et al. Endocrinol Metab Clin North Am. 2006 Dec;35(4):793-805, ix-x. doi: 10.1016/j.ecl.2006.09.010. Endocrinol Metab Clin North Am. 2006. PMID: 17127147 Review.

10

The altered adrenal axis and treatment with glucocorticoids during critical illness.

Mesotten D, Vanhorebeek I, Van den Berghe G. Mesotten D, et al. Nat Clin Pract Endocrinol Metab. 2008 Sep;4(9):496-505. doi: 10.1038/ncpendmet0921. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18695699 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page